生命科学资讯

Charles River sells its CDMO and European discovery businesses

Accent axes a cancer study; Werewolf considers its options

Alkermes CEO Richard Pops to retire after 35-year tenure

States sue Kennedy over US childhood vaccine overhaul

Novo Nordisk teams with Langer-founded biotech for oral obesity drugs

Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy

GSK to buy pulmonary hypertension biotech 35Pharma for $950M

HHS commits up to $144M to study anti-aging approaches via ARPA-H

Novo Nordisk to slash Wegovy list price in half in 2027

Industry groups lay legal groundwork against pricing demos

UCLA spinout raises $11M to test microbiome-based weight loss therapy

Can the ACCESS pilot crack a longstanding barrier for startups?

BioMarin fails to find buyer, pulls Roctavian gene therapy off market

Patient dies in MacroGenics' cancer study, FDA puts trial on hold

Beam Therapeutics' new PKU program; Protara's bladder cancer data

Abcuro drug fails muscle weakness trial, development to continue

Immedica wins accelerated approval for once-rejected rare disease drug

New biotech Slate Medicines raises $130M for migraine drug from China

Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market

Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push